597 related articles for article (PubMed ID: 27453164)
21. HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.
Napolitano A; Antoine DJ; Pellegrini L; Baumann F; Pagano I; Pastorino S; Goparaju CM; Prokrym K; Canino C; Pass HI; Carbone M; Yang H
Clin Cancer Res; 2016 Jun; 22(12):3087-96. PubMed ID: 26733616
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases.
Rusch A; Ziltener G; Nackaerts K; Weder W; Stahel RA; Felley-Bosco E
Lung Cancer; 2015 Jan; 87(1):77-9. PubMed ID: 25468148
[TBL] [Abstract][Full Text] [Related]
24. Asbestos-related lung cancer and malignant mesothelioma of the pleura: selected current issues.
Markowitz S
Semin Respir Crit Care Med; 2015 Jun; 36(3):334-46. PubMed ID: 26024342
[TBL] [Abstract][Full Text] [Related]
25. [Malignant mesothelioma and constitutional BAP1 gene mutations].
Neviere Z; Berthet P; Polycarpe F; Dubos-Arvis C; Dô P; Gervais R
Rev Mal Respir; 2019 Feb; 36(2):241-248. PubMed ID: 30686559
[TBL] [Abstract][Full Text] [Related]
26. Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
Carbone M; Pass HI; Ak G; Alexander HR; Baas P; Baumann F; Blakely AM; Bueno R; Bzura A; Cardillo G; Churpek JE; Dianzani I; De Rienzo A; Emi M; Emri S; Felley-Bosco E; Fennell DA; Flores RM; Grosso F; Hayward NK; Hesdorffer M; Hoang CD; Johansson PA; Kindler HL; Kittaneh M; Krausz T; Mansfield A; Metintas M; Minaai M; Mutti L; Nielsen M; O'Byrne K; Opitz I; Pastorino S; Pentimalli F; de Perrot M; Pritchard A; Ripley RT; Robinson B; Rusch V; Taioli E; Takinishi Y; Tanji M; Tsao AS; Tuncer AM; Walpole S; Wolf A; Yang H; Yoshikawa Y; Zolondick A; Schrump DS; Hassan R
J Thorac Oncol; 2022 Jul; 17(7):873-889. PubMed ID: 35462085
[TBL] [Abstract][Full Text] [Related]
27. High incidence of lung cancer and malignant mesothelioma linked to erionite fibre exposure in a rural community in Central Mexico.
Ortega-Guerrero MA; Carrasco-Núñez G; Barragán-Campos H; Ortega MR
Occup Environ Med; 2015 Mar; 72(3):216-8. PubMed ID: 25231672
[TBL] [Abstract][Full Text] [Related]
28. Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.
Ribeiro C; Campelos S; Moura CS; Machado JC; Justino A; Parente B
Ann Oncol; 2013 Aug; 24(8):2147-50. PubMed ID: 23585512
[TBL] [Abstract][Full Text] [Related]
29. Past and current asbestos exposure and future mesothelioma risks in Britain: The Inhaled Particles Study (TIPS).
Gilham C; Rake C; Hodgson J; Darnton A; Burdett G; Peto Wild J; Newton M; Nicholson AG; Davidson L; Shires M; Treasure T; Peto J;
Int J Epidemiol; 2018 Dec; 47(6):1745-1756. PubMed ID: 29534192
[TBL] [Abstract][Full Text] [Related]
30. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.
Baumann F; Flores E; Napolitano A; Kanodia S; Taioli E; Pass H; Yang H; Carbone M
Carcinogenesis; 2015 Jan; 36(1):76-81. PubMed ID: 25380601
[TBL] [Abstract][Full Text] [Related]
31. Mesothelioma associated with environmental exposures.
Pasetto R; Comba P; Marconi A
Med Lav; 2005; 96(4):330-7. PubMed ID: 16457429
[TBL] [Abstract][Full Text] [Related]
32. Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members.
Kittaneh M; Berkelhammer C
J Transl Med; 2018 Jul; 16(1):194. PubMed ID: 30001711
[TBL] [Abstract][Full Text] [Related]
33. A Tumor-Specific Neo-Antigen Caused by a Frameshift Mutation in BAP1 Is a Potential Personalized Biomarker in Malignant Peritoneal Mesothelioma.
Lai J; Zhou Z; Tang XJ; Gao ZB; Zhou J; Chen SQ
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187383
[TBL] [Abstract][Full Text] [Related]
34. Mesothelioma and Colorectal Cancer: Report of Four Cases with Synchronous and Metachronous Presentation.
Serio G; Pezzuto F; Fortarezza F; Marzullo A; Delfino MC; d'Amati A; Romano DE; Maniglio S; Caporusso C; Lettini T; Cavone D; Vimercati L
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269773
[TBL] [Abstract][Full Text] [Related]
35. Malignant Mesothelioma Mortality - United States, 1999-2015.
Mazurek JM; Syamlal G; Wood JM; Hendricks SA; Weston A
MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(8):214-218. PubMed ID: 28253224
[TBL] [Abstract][Full Text] [Related]
36. Malignant mesothelioma due to non-occupational asbestos exposure from the Italian national surveillance system (ReNaM): epidemiology and public health issues.
Marinaccio A; Binazzi A; Bonafede M; Corfiati M; Di Marzio D; Scarselli A; Verardo M; Mirabelli D; Gennaro V; Mensi C; Schallemberg G; Merler E; Negro C; Romanelli A; Chellini E; Silvestri S; Cocchioni M; Pascucci C; Stracci F; Ascoli V; Trafficante L; Angelillo I; Musti M; Cavone D; Cauzillo G; Tallarigo F; Tumino R; Melis M;
Occup Environ Med; 2015 Sep; 72(9):648-55. PubMed ID: 26045315
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry.
Corfiati M; Scarselli A; Binazzi A; Di Marzio D; Verardo M; Mirabelli D; Gennaro V; Mensi C; Schallemberg G; Merler E; Negro C; Romanelli A; Chellini E; Silvestri S; Cocchioni M; Pascucci C; Stracci F; Romeo E; Trafficante L; Angelillo I; Menegozzo S; Musti M; Cavone D; Cauzillo G; Tallarigo F; Tumino R; Melis M; Iavicoli S; Marinaccio A;
BMC Cancer; 2015 Apr; 15():286. PubMed ID: 25885893
[TBL] [Abstract][Full Text] [Related]
38. Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.
Sneddon S; Dick I; Lee YCG; Musk AWB; Patch AM; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J
Lung Cancer; 2018 May; 119():64-70. PubMed ID: 29656754
[TBL] [Abstract][Full Text] [Related]
39. The established and future biomarkers of malignant pleural mesothelioma.
Panou V; Vyberg M; Weinreich UM; Meristoudis C; Falkmer UG; Røe OD
Cancer Treat Rev; 2015 Jun; 41(6):486-95. PubMed ID: 25979846
[TBL] [Abstract][Full Text] [Related]
40. The role of environmental carcinogens, viruses and genetic predisposition in the pathogenesis of mesothelioma.
Powers A; Carbone M
Cancer Biol Ther; 2002; 1(4):348-53. PubMed ID: 12432244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
